These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19098386)

  • 61. Dopaminergic and cholinergic learning mechanisms in nicotine addiction.
    Subramaniyan M; Dani JA
    Ann N Y Acad Sci; 2015 Sep; 1349(1):46-63. PubMed ID: 26301866
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nicotine and food induced dopamine release in the nucleus accumbens of the rat: putative role of alpha7 nicotinic receptors in the ventral tegmental area.
    Schilström B; Svensson HM; Svensson TH; Nomikos GG
    Neuroscience; 1998 Aug; 85(4):1005-9. PubMed ID: 9681941
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Direct effect of nicotine on mesolimbic dopamine release in rat nucleus accumbens shell.
    Kleijn J; Folgering JH; van der Hart MC; Rollema H; Cremers TI; Westerink BH
    Neurosci Lett; 2011 Apr; 493(1-2):55-8. PubMed ID: 21352892
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nicotine-Induced Conditional Place Preference Is Affected by Head Injury: Correlation with Dopamine Release in the Nucleus Accumbens Shell.
    Chen YH; Kuo TT; Huang EY; Hoffer BJ; Kao JH; Chou YC; Chiang YH; Miller J
    Int J Neuropsychopharmacol; 2018 Oct; 21(10):949-961. PubMed ID: 29905798
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin.
    Turner PC; Baquero MT; Yuan S; Thoennes SR; Moyer RW
    Virology; 2000 Jul; 272(2):267-80. PubMed ID: 10873770
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Attenuation of nicotine-induced rewarding effects in A2A knockout mice.
    Castañé A; Soria G; Ledent C; Maldonado R; Valverde O
    Neuropharmacology; 2006 Sep; 51(3):631-40. PubMed ID: 16793068
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tissue-type plasminogen activator induces synaptic vesicle endocytosis in cerebral cortical neurons.
    Yepes M; Wu F; Torre E; Cuellar-Giraldo D; Jia D; Cheng L
    Neuroscience; 2016 Apr; 319():69-78. PubMed ID: 26820595
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Plasminogen-induced aggregation of PANC-1 cells requires conversion to plasmin and is inhibited by endogenous plasminogen activator inhibitor-1.
    Deshet N; Lupu-Meiri M; Espinoza I; Fili O; Shapira Y; Lupu R; Gershengorn MC; Oron Y
    J Cell Physiol; 2008 Sep; 216(3):632-9. PubMed ID: 18366077
    [TBL] [Abstract][Full Text] [Related]  

  • 69. L-theanine inhibits nicotine-induced dependence via regulation of the nicotine acetylcholine receptor-dopamine reward pathway.
    Di X; Yan J; Zhao Y; Chang Y; Zhao B
    Sci China Life Sci; 2012 Dec; 55(12):1064-74. PubMed ID: 23233221
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury.
    Akassoglou K; Kombrinck KW; Degen JL; Strickland S
    J Cell Biol; 2000 May; 149(5):1157-66. PubMed ID: 10831618
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Plasmin-induced migration requires signaling through protease-activated receptor 1 and integrin alpha(9)beta(1).
    Majumdar M; Tarui T; Shi B; Akakura N; Ruf W; Takada Y
    J Biol Chem; 2004 Sep; 279(36):37528-34. PubMed ID: 15247268
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cannabinoid receptor GPR55 activation blocks nicotine use disorder by regulation of AMPAR phosphorylation.
    Liu Q; Yu J; Li X; Guo Y; Sun T; Luo L; Ren J; Jiang W; Zhang R; Yang P; Yang Q
    Psychopharmacology (Berl); 2021 Nov; 238(11):3335-3346. PubMed ID: 34648060
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lifetime caffeine and adolescent nicotine exposure in mice: effects on anxiety-like behavior and reward.
    Dutra-Tavares AC; Ribeiro-Carvalho A; Nunes F; Araújo UC; Bruno V; Marcourakis T; Filgueiras CC; Manhães AC; Abreu-Villaça Y
    J Dev Orig Health Dis; 2023 Jun; 14(3):362-370. PubMed ID: 37009674
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Basic and translational research on proteinase-activated receptors: preface.
    Hirano K; Kawabata A
    J Pharmacol Sci; 2008 Dec; 108(4):406-7. PubMed ID: 19098385
    [No Abstract]   [Full Text] [Related]  

  • 75. Plasmin reduces fibronectin deposition by mesangial cells in a protease-activated receptor-1 independent manner.
    Waasdorp M; Duitman J; Spek CA
    Biochem Biophys Rep; 2017 Jul; 10():152-156. PubMed ID: 29114573
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Neuro-Immune Hemostasis: Homeostasis and Diseases in the Central Nervous System.
    De Luca C; Colangelo AM; Alberghina L; Papa M
    Front Cell Neurosci; 2018; 12():459. PubMed ID: 30534057
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Activation of astrocytic PAR1 receptors in the rat nucleus of the solitary tract regulates breathing through modulation of presynaptic TRPV1.
    Huda R; Chang Z; Do J; McCrimmon DR; Martina M
    J Physiol; 2018 Feb; 596(3):497-513. PubMed ID: 29235097
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Neuro-Coagulopathy: Blood Coagulation Factors in Central Nervous System Diseases.
    De Luca C; Virtuoso A; Maggio N; Papa M
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29023416
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Improvement of Psychotic Symptoms and the Role of Tissue Plasminogen Activator.
    Hoirisch-Clapauch S; Nardi AE
    Int J Mol Sci; 2015 Nov; 16(11):27550-60. PubMed ID: 26593907
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Activation of protease activated receptor 1 increases the excitability of the dentate granule neurons of hippocampus.
    Han KS; Mannaioni G; Hamill CE; Lee J; Junge CE; Lee CJ; Traynelis SF
    Mol Brain; 2011 Aug; 4():32. PubMed ID: 21827709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.